Biodesix
BDSX
Biodesix (BDSX) earnings history
Most recent quarter
- Fiscal period
- Q2 2026
- Period end
- Jun 30, 2026
- EPS actual
- −$0.71
- EPS estimate
- −$0.90
- EPS surprise
- +21.27%
- Revenue surprise
- +3.21%
- Revenue
- $26.9M
- Revenue estimate
- $26.0M
- Reported
- Aug 5, 2026
Earnings history
| Period | Reported | EPS estimate | EPS actual | Surprise | Revenue | Filing |
|---|---|---|---|---|---|---|
| Q2 2026 | Aug 5, 2026 | −$0.90 | −$0.71 | +21.27% | $26.9M | SEC |
| Q1 2026 | May 4, 2026 | −$1.13 | −$0.81 | +28.31% | $25.6M | SEC |
| Q4 2025 | Feb 26, 2026 | −$0.86 | −$0.49 | +43.04% | $28.8M | SEC |
| Q3 2025 | Nov 3, 2025 | −$1.49 | −$1.16 | +22.15% | $21.8M | SEC |
| Q2 2025 | Aug 7, 2025 | −$1.38 | −$1.60 | −16.14% | $20.0M | SEC |
| Q1 2025 | May 13, 2025 | −$1.40 | −$1.60 | −14.64% | $18.0M | SEC |
| Q4 2024 | Mar 3, 2025 | −$1.34 | −$1.20 | +10.73% | $20.4M | SEC |
| Q3 2024 | Nov 1, 2024 | −$1.46 | −$1.40 | +4.29% | $18.2M | SEC |
| Q2 2024 | Aug 7, 2024 | −$1.84 | −$1.60 | +13.10% | $17.9M | SEC |
| Q1 2024 | May 8, 2024 | −$2.84 | −$2.80 | +1.50% | $14.8M | SEC |
| Q4 2023 | Mar 1, 2024 | −$2.18 | −$2.00 | +8.30% | $14.7M | SEC |
| Q3 2023 | Nov 7, 2023 | −$2.93 | −$2.80 | +4.54% | $13.5M | SEC |
| Q2 2023 | Aug 7, 2023 | −$4.12 | −$3.40 | +17.57% | $11.9M | SEC |
| Q1 2023 | May 11, 2023 | −$4.73 | −$4.80 | −1.41% | $9.1M | SEC |
| Q4 2022 | Mar 6, 2023 | −$5.55 | −$7.00 | −26.10% | $9.6M | SEC |
| Q3 2022 | Nov 3, 2022 | −$6.55 | −$6.80 | −3.77% | $11.1M | SEC |
| Q2 2022 | Aug 4, 2022 | −$9.30 | −$8.00 | +13.98% | $10.9M | SEC |
| Q1 2022 | May 11, 2022 | −$8.50 | −$10.00 | −17.65% | $6.5M | SEC |
| Q4 2021 | Mar 14, 2022 | −$9.84 | −$9.80 | +0.40% | $7.2M | SEC |
| Q3 2021 | Nov 15, 2021 | −$9.55 | −$8.20 | +14.14% | $6.5M | SEC |
Quarterly revenue
Frequently asked questions
When did Biodesix (BDSX) last report earnings?
Biodesix last reported on Aug 5, 2026, covering fiscal Q2 2026.
Did BDSX beat earnings estimates?
Yes. Biodesix reported EPS of −$0.71 for Q2 2026 against a −$0.90 estimate — a 21.27% beat.
How much revenue did BDSX report last quarter?
Biodesix reported $26.9M in revenue for Q2 2026, against a consensus estimate of $26.0M.
Earnings figures may be restated, revised or corrected by the issuer. Past results do not indicate future performance.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.